Prev Close | 6.72 |
Open | 6.78 |
Day Low/High | 6.70 / 6.78 |
52 Wk Low/High | 4.98 / 8.14 |
Volume | 591.19K |
Avg Volume | 1.10M |
Prev Close | 6.72 |
Open | 6.78 |
Day Low/High | 6.70 / 6.78 |
52 Wk Low/High | 4.98 / 8.14 |
Volume | 591.19K |
Avg Volume | 1.10M |
Exchange | NYSE |
Shares Outstanding | 6.00B |
Market Cap | 40.18B |
EPS | 0.40 |
Div & Yield | 0.05 (0.76%) |
Markets were mixed on the first day of May trading.
The Bank of England said none of the banks will need to raise fresh capital following its fourth year of stress tests
Bitcoin market cap now bigger than RBS and Credit Suisse combined
Investors should keep a close eye on homebuilders, REITs and so-called challenger banks.
Japanese airbag maker Takata files for chapter 11 bankruptcy. The company faced billions of dollars in liabilities over its defective airbags.
RBS Enters Last Ditch Round of Settlement Talks
Here is you round-up of Friday's earnings reports
European Stocks Set For Flat Open Ahead of UK GDP, Eurozone Inflation Data
Between overhead resistance and a flat-to-declining OBV line, we have to side with the bears.
A deeper pullback may be at hand, but that isn't such a bad thing.
RBS posted a larger-than-expected full year loss of £6.95 billion after massive litigation and writedown costs hammered the bottom line of the taxpayer owned bank.
Round-up of the financial news from around the world
Royal Bank of Scotland shares surged Monday after the state-owned lender said that it's preparing to the abandon a plan to sell part of its retail unit
European stocks traded higher across the board Monday as takeover news and solid economic sentiment offset ongoing concerns over political uncertainty in the region
Here is what to watch out of Europe this week.
Keep an eye on these earnings reports.
Johnson & Johnson is buying the Swiss biotech Actelion for $30 billion.
Shares keep bumping up against resistance in the $6 to $7 range, and further declines are possible.
These names show technical characteristics of bullish or bearish reversal patterns.
Brexit and the U.S. election have introduced far more uncertainty than previously assumed.
Investors should keep an eye on French stocks, despite a reputation for bureaucracy.
Theresa May is crushing the U.K. currency. Time for Mark Carney to make the next move.
The U.S. National Credit Union Administration saYS the Edinburgh lender will pay $1.1 billion to settle claims it sold toxic mortgage-backed securities to credit unions that later failed.
The Wells Fargo board is calling for clawbacks while Nike's quarter disappoints investors despite beating estimates.
Emerging clarity on the Brexit conditions reveals opportunities.
Analysts believe the stock has 15% upside potential. I wouldn't bet on that.
Following these activists can pay off; they know their banks inside out.